ZenNews› Health› How to Get Medical Cannabis in the UK: The Patien… Health How to Get Medical Cannabis in the UK: The Patient Guide Who can prescribe, what it costs, which diagnoses qualify — step by step through the British system By ZenNews Editorial Mar 30, 2026 3 min read Updated: Jun 28, 2026 Medical cannabis has been legal in the United Kingdom since 2018 — yet for patients, the path to a prescription involves considerable effort and personal expenditure. Here is what is actually possible, who may prescribe, and what international patients visiting the UK need to understand.Table of ContentsWho May Prescribe Medical Cannabis?NHS or Private? The Reality of the British SystemWhich Diagnoses Are Recognised?Available Products and Supply ChainInternational Patients Visiting the UKStep-by-Step: How the Private Clinic Process WorksRelated Articles At a GlanceGetting a medical cannabis prescription in the UK is complex and often requires private funding.Specialist doctors, not GPs, are authorized to prescribe cannabis-based medicines.The vast majority of UK patients access medical cannabis through private clinics. Who May Prescribe Medical Cannabis? Not every doctor in the UK may prescribe cannabis. Only Specialist Doctors — consultants with a specific registration with the General Medical Council (GMC) — are authorised to prescribe cannabis-based medicinal products (CBMPs). NHS General Practitioners (GPs) are not among them. In practice: a patient seeking an NHS cannabis prescription must first be referred by their GP to a consultant. That consultant may then issue a prescription — but in NHS practice, this is exceptionally rare. Criteria are stringent: other treatments must demonstrably have failed, the diagnosis must be clear, and there must be robust clinical evidence for the benefit of cannabis in that specific case. Image: Leafme.co.uk NHS or Private? The Reality of the British System The overwhelming majority of UK patients receiving medical cannabis do so through private clinics, not the NHS. It is estimated that fewer than 20 NHS cannabis prescriptions have been issued since legalisation in 2018, while the private sector now serves tens of thousands of patients. Established private providers include: Sapphire Medical Clinics — among the first and largest private cannabis clinics in the UK The Medical Cannabis Clinics (TMCC) — specialising in chronic pain and neurological conditions Lyphe Group — offering online consultations and rapid access pathways Releaf — a digital-first platform with a telemedicine model Mamedica — focusing on chronic conditions with high patient volumes Private cannabis treatment typically costs between £200 and £400 per month for medication, with initial consultation fees ranging from £50 to £150. NHS reimbursement is not available. Patients should also note that not every pharmacy is licensed to dispense cannabis-based medicinal products — the prescribing clinic will advise on approved dispensing pharmacies. Which Diagnoses Are Recognised? There is no definitive statutory list of qualifying conditions. Clinical judgement rests with the prescribing specialist. In practice, cannabis-based medicines are most frequently prescribed for: Chronic pain (neuropathic, musculoskeletal, post-surgical) Multiple sclerosis — particularly spasticity (Sativex is formally licensed by the MHRA for this indication) Chemotherapy-induced nausea and vomiting Severe epilepsy, especially in children (Epidyolex is MHRA-licensed for Dravet syndrome and Lennox-Gastaut syndrome) Post-traumatic stress disorder (PTSD) Anxiety disorders and sleep disorders (at some private providers) Available Products and Supply Chain Cannabis medicines dispensed in the UK are predominantly imported. Key producers and suppliers include: Bedrocan (Netherlands) — standardised flower products with controlled THC/CBD ratios Aurora (Canada) — broad product range including oils and dried flower Tilray (Canada/Portugal) — one of the largest global cannabis producers GW Pharmaceuticals / Jazz Pharmaceuticals (UK) — manufacturers of Epidyolex and Sativex Spectrum Therapeutics — Canadian supplier with UK market presence International Patients Visiting the UK For patients from Germany or elsewhere in Europe who are visiting the UK, several critical points apply: A German cannabis prescription is not recognised in the United Kingdom. Anyone requiring cannabis-based medication while in the UK must consult a British specialist clinic — telemedicine appointments are available. The European Health Insurance Card (EHIC) or Global Health Insurance Card (GHIC) does not cover cannabis treatment costs. It is also illegal to bring German-prescribed cannabis medicines into the UK — importation is treated as a supply offence. Our TakeThis article details the current landscape of medical cannabis access in the UK, highlighting the limitations of the NHS and the dominance of private providers. Readers should understand the significant barriers to NHS access and the prevalent role of private clinics in delivering treatment. Step-by-Step: How the Private Clinic Process Works Step 1: Online registration with a private cannabis clinic Step 2: Telemedicine initial consultation with a registered specialist Step 3: Submission of medical records (diagnosis history, previous treatments tried) Step 4: Prescription issued by the specialist if clinically appropriate Step 5: Licensed dispensing pharmacy contacted; medication delivered or collected Step 6: Regular follow-up consultations for dose review and monitoring Related Articles Medical Cannabis in the UK: The Complete Guide Cannabis Law UK: Class B, Exceptions and Visitor Guidance Share Share X Facebook WhatsApp Copy link How do you feel about this? 🔥 0 😲 0 🤔 0 👍 0 😢 0 cannabis uk medical Z ZenNews Editorial Editorial The ZenNews editorial team covers the most important events from the US, UK and around the world around the clock — independent, reliable and fact-based. You might also like › Health NHS Waiting Times Crisis 2026 — Waiting Lists Hit Record High 05 Jul 2026 Health Maternity Review Fallout Puts Starmer's NHS Pledge to Test 04 Jul 2026 Health HPV Vaccine Cuts Cervical Cancer Deaths to Near Zero 26 Jun 2026 Health NHS Launches Drug to Delay Type 1 Diabetes Onset 26 Jun 2026 Health Wegovy Pill Form Signals Shift in NHS Obesity Strategy 23 Jun 2026 Health NHS Corridor Care Crisis Deepens as Daily Toll Hits 3,000 22 Jun 2026 Health NHS GP Surgery Closures at Record High — Millions Lose Access to Local Doctor 30 May 2026 Health Fit Note System 'Broken', Says Government as Pilot Scheme Launched 21 May 2026 Also interesting › UK Politics Reeves Frames Handover to Burnham as Test of Economic Stability 4 hrs ago UK Politics Burnham's Path to No 10 Sets Up Rapid Labour Reset 10 Jul 2026 Sports England's Azteca Win Reignites Debate Over Tuchel's Tactical Overhaul 06 Jul 2026 Economy Sick Days Cost UK Economy Billions, Ex-John Lewis Chief Warns 05 Jul 2026 More in Health › Health NHS Waiting Times Crisis 2026 — Waiting Lists Hit Record High 05 Jul 2026 Health Maternity Review Fallout Puts Starmer's NHS Pledge to Test 04 Jul 2026 Health HPV Vaccine Cuts Cervical Cancer Deaths to Near Zero 26 Jun 2026 Health NHS Launches Drug to Delay Type 1 Diabetes Onset 26 Jun 2026 Discover more — Health NHS Waiting Times Crisis 2026 — Waiting Lists Hit Record High05 Jul 2026 Maternity Review Fallout Puts Starmer's NHS Pledge to Test04 Jul 2026 ← Health NHS Faces Record GP Shortages as Waiting Times Hit Crisis Health → NHS cancer treatment delays worsen as funding gaps widen